海能實業(300787.SZ)及下屬公司擬向銀行申請不超5.91億元綜合授信額度
格隆匯4月8日丨海能實業(300787.SZ)公佈,為滿足生產經營及業務發展對流動資金的需求,公司及合併報表範圍內下屬公司擬向銀行申請不超過人民幣5.91億元的綜合授信額度,授信期限不超過兩年。上述綜合授信用途包括但不限於流動資金貸款、各類保函、信用證、銀行承兑匯票等銀行授信業務(具體授信銀行、授信額度、授信期限以實際審批為準),公司及合併報表範圍內下屬公司可共享上述額度。此授信額度不等於實際融資金額,具體融資金額依據公司及合併報表範圍內下屬公司運營資金的實際需求確定,授信額度可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.